{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:30:30Z","timestamp":1780723830791,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"am","delay-in-days":287,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jaut.2022.102912","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:27:27Z","timestamp":1662942447000},"page":"102912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Glucocorticoid use as a cause of non-cellular immune response to SARS-Cov2 Spike in patients with immune system diseases"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5098-5002","authenticated-orcid":false,"given":"Yves","family":"Renaudineau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Sailler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Abravanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Izopet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Delourme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Biotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Ciron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Treiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Congy-Jolivet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Bost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Blancher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jaut.2022.102912_bib1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"79","author":"Gianfrancesco","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102912_bib2","article-title":"SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases","volume":"5","author":"Larionova","year":"2022","journal-title":"J Transl Autoimmun"},{"issue":"10","key":"10.1016\/j.jaut.2022.102912_bib3","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/annrheumdis-2021-220647","article-title":"Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study","volume":"80","author":"Furer","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.jaut.2022.102912_bib4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/annrheumdis-2021-221876","article-title":"Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases","volume":"81","author":"Arumahandi de Silva","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102912_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.834981","article-title":"Antigen specific humoral and cellular immunity following SARS-CoV-2 vaccination in ANCA-associated vasculitis patients receiving B-cell depleting therapy","volume":"13","author":"Marty","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.jaut.2022.102912_bib6","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2022.102912_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108979","article-title":"Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response","volume":"237","author":"Renaudineau","year":"2022","journal-title":"Clin. Immunol."},{"issue":"10224","key":"10.1016\/j.jaut.2022.102912_bib8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jaut.2022.102912_bib9","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.jinf.2022.01.044","article-title":"Antibody titers and breakthrough infections with Omicron SARS-CoV-2","volume":"84","author":"Dimeglio","year":"2022","journal-title":"J. Infect."},{"issue":"5","key":"10.1016\/j.jaut.2022.102912_bib10","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/ajt.16950","article-title":"Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients","volume":"22","author":"Kamar","year":"2022","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jaut.2022.102912_bib11","series-title":"Humoral and Cellular Response to COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases under Real-Life Conditions","author":"Krasselt","year":"2022"},{"issue":"1","key":"10.1016\/j.jaut.2022.102912_bib12","doi-asserted-by":"crossref","first-page":"e1037","DOI":"10.1093\/cid\/ciab954","article-title":"Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study","volume":"75","author":"Madelon","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"19","key":"10.1016\/j.jaut.2022.102912_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10194357","article-title":"Frequency and factors of indeterminate QuantiFERON-TB gold in-tube and QuantiFERON-TB gold PLUS test results in rheumatic diseases","volume":"10","author":"Ahn","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.jaut.2022.102912_bib14","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1038\/s41598-021-86053-0","article-title":"Low-dose steroids are associated with indeterminate QuantiFERON-TB Gold In-Tube assay results in immunocompetent children","volume":"11","author":"Kim","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.jaut.2022.102912_bib15","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/rheumatology\/kez390","article-title":"High rate of indeterminate results of the QuantiFERON-TB Gold in-tube test, third generation, in patients with systemic vasculitis","volume":"59","author":"Rousset","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2022.102912_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221089586","article-title":"Immunogenicity and safety of inactivated and mRNA COVID-19 vaccines in patients with systemic lupus erythematosus","volume":"14","author":"So","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"3","key":"10.1016\/j.jaut.2022.102912_bib17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/agm2.12075","article-title":"Glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) gene polymorphism (rs4998386) and Parkinson's disease susceptibility: a meta-analysis","volume":"2","author":"Nepal","year":"2019","journal-title":"Aging Med (Milton)"},{"issue":"1","key":"10.1016\/j.jaut.2022.102912_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1081-1206(10)61380-4","article-title":"Effects of long-term low-dose corticosteroid therapy on humoral immunity","volume":"97","author":"Fedor","year":"2006","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2022.102912_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41577-020-00464-0","article-title":"Glucocorticoids in T cell development, differentiation and function","volume":"21","author":"Taves","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2022.102912_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103785","article-title":"The humoral response to SARS-COV-2 vaccines in MS patients: a case series exploring the impact of DMT, lymphocyte count, immunoglobulins, and vaccine type","volume":"61","author":"Jakubecz","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"10.1016\/j.jaut.2022.102912_bib21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/art.41937","article-title":"Evaluation of immune response and disease status in systemic lupus erythematosus patients following SARS-CoV-2 vaccination","volume":"74","author":"Izmirly","year":"2022","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2022.102912_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-002050","article-title":"Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses","volume":"8","author":"Saleem","year":"2022","journal-title":"RMD Open"},{"issue":"6","key":"10.1016\/j.jaut.2022.102912_bib23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.0300-9475.2004.01514.x","article-title":"Cortisol and dehydroepiandrosterone affect the response of peripheral blood mononuclear cells to mycobacterial antigens during tuberculosis","volume":"60","author":"Mahuad","year":"2004","journal-title":"Scand. J. Immunol."},{"issue":"10","key":"10.1016\/j.jaut.2022.102912_bib24","doi-asserted-by":"crossref","first-page":"e724","DOI":"10.1016\/S2665-9913(21)00247-2","article-title":"COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses","volume":"3","author":"Fagni","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"10.1016\/j.jaut.2022.102912_bib25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/cimm.1995.1101","article-title":"Antigen presentation in protein-energy malnutrition","volume":"163","author":"Redmond","year":"1995","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jaut.2022.102912_bib26","article-title":"Effects of acute critical illnesses on the performance of interferon-gamma release assay","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.jaut.2022.102912_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181887","article-title":"Impact of diabetes mellitus on indeterminate results of the QuantiFERON TB Gold In-Tube test: a propensity score matching analysis","volume":"12","author":"Shin","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jaut.2022.102912_bib28","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.cgh.2017.11.038","article-title":"Factors that contribute to indeterminate results from the QuantiFERON-TB gold in-tube test in patients with inflammatory bowel disease","volume":"16","author":"Kaur","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.jaut.2022.102912_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10030636","article-title":"SARS-CoV-2 mRNA vaccine-induced cellular and humoral immunity in hemodialysis patients","volume":"10","author":"Kwiatkowska","year":"2022","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.jaut.2022.102912_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/nu12123679","article-title":"Malnutrition: percentage and association with prognosis in patients hospitalized for coronavirus disease 2019","volume":"12","author":"Allard","year":"2020","journal-title":"Nutrients"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122001202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122001202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:29:50Z","timestamp":1760257790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841122001202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":30,"alternative-id":["S0896841122001202"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102912","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucocorticoid use as a cause of non-cellular immune response to SARS-Cov2 Spike in patients with immune system diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102912","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102912"}}